518 related articles for article (PubMed ID: 16905561)
1. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
[TBL] [Abstract][Full Text] [Related]
2. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.
Burwick RM; Ramsay PP; Haines JL; Hauser SL; Oksenberg JR; Pericak-Vance MA; Schmidt S; Compston A; Sawcer S; Cittadella R; Savettieri G; Quattrone A; Polman CH; Uitdehaag BM; Zwemmer JN; Hawkins CP; Ollier WE; Weatherby S; Enzinger C; Fazekas F; Schmidt H; Schmidt R; Hillert J; Masterman T; Hogh P; Niino M; Kikuchi S; Maciel P; Santos M; Rio ME; Kwiecinski H; Zakrzewska-Pniewska B; Evangelou N; Palace J; Barcellos LF
Neurology; 2006 May; 66(9):1373-83. PubMed ID: 16682670
[TBL] [Abstract][Full Text] [Related]
3. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
4. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.
Wu JS; James I; Wei Qiu ; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
Mult Scler; 2010 May; 16(5):526-32. PubMed ID: 20207784
[TBL] [Abstract][Full Text] [Related]
5. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
Stankovich J; Butzkueven H; Marriott M; Chapman C; Tubridy N; Tait BD; Varney MD; Taylor BV; Foote SJ; ; Kilpatrick TJ; Rubio JP
Tissue Antigens; 2009 Jul; 74(1):17-21. PubMed ID: 19392788
[TBL] [Abstract][Full Text] [Related]
6. Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis.
Ramagopalan SV; Byrnes JK; Dyment DA; Guimond C; Handunnetthi L; Disanto G; Yee IM; Ebers GC; Sadovnick AD
J Hum Genet; 2009 Sep; 54(9):547-9. PubMed ID: 19629136
[TBL] [Abstract][Full Text] [Related]
7. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
[TBL] [Abstract][Full Text] [Related]
8. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex.
Chao MJ; Ramagopalan SV; Herrera BM; Lincoln MR; Dyment DA; Sadovnick AD; Ebers GC
Hum Mol Genet; 2009 Jan; 18(2):261-6. PubMed ID: 19098025
[TBL] [Abstract][Full Text] [Related]
9. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.
Chao MJ; Barnardo MC; Lui GZ; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Sadovnick AD; Ebers GC
Hum Mol Genet; 2007 Aug; 16(16):1951-8. PubMed ID: 17584771
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognition.
Van der Walt A; Stankovich J; Bahlo M; Taylor BV; Van der Mei IA; Foote SJ; Rubio JP; Kilpatrick TJ; Butzkueven H
Mult Scler; 2011 Mar; 17(3):344-52. PubMed ID: 21149397
[TBL] [Abstract][Full Text] [Related]
11. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance.
Dyment DA; Herrera BM; Cader MZ; Willer CJ; Lincoln MR; Sadovnick AD; Risch N; Ebers GC
Hum Mol Genet; 2005 Jul; 14(14):2019-26. PubMed ID: 15930013
[TBL] [Abstract][Full Text] [Related]
12. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice.
Kaushansky N; Altmann DM; Ascough S; David CS; Lassmann H; Ben-Nun A
J Immunol; 2009 Sep; 183(5):3531-41. PubMed ID: 19648275
[TBL] [Abstract][Full Text] [Related]
13. HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosis.
Cournu-Rebeix I; Génin E; Leray E; Babron MC; Cohen J; Gout C; Alizadeh M; Perdry H; Semana G; Brassat D; Clerget-Darpoux F; Yaouanq J; Edan G; Rosenheim M; Fontaine B
Genes Immun; 2008 Sep; 9(6):570-4. PubMed ID: 18615093
[TBL] [Abstract][Full Text] [Related]
14. Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort.
Wu JS; Qiu W; Castley A; James I; Joseph J; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
J Neurol Sci; 2010 Jan; 288(1-2):63-7. PubMed ID: 19879597
[TBL] [Abstract][Full Text] [Related]
15. Mediterranean and Amerindian MHC class II alleles are associated with multiple sclerosis in Mexicans.
Aláez C; Corona T; Ruano L; Flores H; Loyola M; Gorodezky C
Acta Neurol Scand; 2005 Nov; 112(5):317-22. PubMed ID: 16218914
[TBL] [Abstract][Full Text] [Related]
16. HLA-DRB1 and month of birth in multiple sclerosis.
Ramagopalan SV; Link J; Byrnes JK; Dyment DA; Giovannoni G; Hintzen RQ; Sundqvist E; Kockum I; Smestad C; Lie BA; Harbo HF; Padyukov L; Alfredsson L; Olsson T; Sadovnick AD; Hillert J; Ebers GC
Neurology; 2009 Dec; 73(24):2107-11. PubMed ID: 20018638
[TBL] [Abstract][Full Text] [Related]
17. Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami.
Harbo HF; Utsi E; Lorentzen AR; Kampman MT; Celius EG; Myhr KM; Lie BA; Mellgren SI; Thorsby E
Tissue Antigens; 2007 Apr; 69(4):299-304. PubMed ID: 17389012
[TBL] [Abstract][Full Text] [Related]
18. Modifying effects of HLA-DRB1 allele interactions on age at onset of multiple sclerosis in Western Australia.
Wu JS; Qiu W; Castley A; James I; Mastaglia FL; Christiansen FT; Carroll WM; Joseph J; Kermode AG
Mult Scler; 2010 Jan; 16(1):15-20. PubMed ID: 19995849
[TBL] [Abstract][Full Text] [Related]
19. Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis.
Silva AM; Bettencourt A; Pereira C; Santos E; Carvalho C; Mendonça D; Costa PP; Monteiro L; Martins B
Mult Scler; 2009 Jun; 15(6):771-4. PubMed ID: 19482867
[TBL] [Abstract][Full Text] [Related]
20. HLA-DRB1 and multiple sclerosis in Malta.
Dean G; Yeo TW; Goris A; Taylor CJ; Goodman RS; Elian M; Galea-Debono A; Aquilina A; Felice A; Vella M; Sawcer S; Compston DA
Neurology; 2008 Jan; 70(2):101-5. PubMed ID: 18057318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
